Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
A health care worker giving a patient a dose of coronavirus vaccine in an assisted living home in Sumter, S.C., on Jan. 26. Photo: Micah Green/Bloomberg via Getty Images
South Carolina health officials have reported the first-known U.S. COVID-19 cases of a fast-spreading variant discovered in South Africa, the Centers for Disease Control and Prevention announced on Thursday.
Why it matters: Though the CDC has "no evidence that infections by this variant cause more severe disease," preliminary data indicates it may spread faster and more easily than other variants.
What they're saying: "CDC’s recommendations for slowing the spread — wearing masks, staying at least 6 feet apart from others, avoiding crowds, ventilating indoor spaces, and washing hands often — will also prevent the spread of this variant," the agency said.
Driving the news: Vaccine developer Novavax announced the results of the phase 3 United Kingdom trial for its coronavirus vaccine on Wednesday, and the company showed that its shot was 60% effective against the South African variant.
- Novavax reported that the vaccine was 85.6% effective against the variant strain first discovered in the U.K., and 95.6% effective against the original coronavirus strain.
The big picture: Moderna, Pfizer and now Novavax have each reported that their vaccines, while still effective, offer less protection against the South African variant.
- On Monday, Minnesota reported America's first-known case of a Brazilian variant of the coronavirus, which also seems to spread more rapidly than the original disease.
- Multiple states reported their first cases of the U.K. variant in late December 2020.